Brief: Cytodyn To Offer No-Cost Testing For Childhood Inflammatory Disease Associated With Covid-19
15/05/2020 11:20
May 15 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN TO OFFER NO-COST EXPLORATORY LABORATORY TESTING
FOR
CHILDHOOD INFLAMMATORY DISEASE ASSOCIATED WITH COVID-19
* CYTODYN INC - CURRENTLY ENROLLING PATIENTS IN TWO CLINICAL
TRIALS FOR COVID-19
Source text for Eikon: ID:nGNX97CJy0
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer